Stay updated on Rucaparib and Nivolumab in Prostate or Endometrial Cancer Clinical Trial

Sign up to get notified when there's something new on the Rucaparib and Nivolumab in Prostate or Endometrial Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Rucaparib and Nivolumab in Prostate or Endometrial Cancer Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    Change Detected
    Summary
    The clinical trial record for rucaparib and nivolumab is displayed, with study details, participation criteria, treatment plan, outcomes, record dates, and a linked protocol document. The record states that the study was terminated due to lack of efficacy and is no longer recruiting.
    Difference
    58%
    Check dated 2026-11-08T14:56:33.000Z thumbnail image
  3. Check
    17 days ago
    Change Detected
    Summary
    The footer revision changed from v3.7.2 to v3.8.0, while the page continues to show a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-11-01T16:12:53.000Z thumbnail image
  4. Check
    24 days ago
    Change Detected
    Summary
    A site-wide NIH notice appears above the ClinicalTrials.gov navigation, announcing a website transition and changes in terminology around artificial intelligence.
    Difference
    1%
    Check dated 2026-10-25T17:07:48.000Z thumbnail image
  5. Check
    31 days ago
    Change Detected
    Summary
    The site footer revision changed from v3.7.1 to v3.7.2 while the study page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-18T20:56:57.000Z thumbnail image
  6. Check
    38 days ago
    Change Detected
    Summary
    The footer site revision changes from v3.7.0 to v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-11T21:53:03.000Z thumbnail image
  7. Check
    52 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error, replacing the expected study record content and showing only the site header and footer.
    Difference
    0.5%
    Check dated 2026-09-27T20:39:48.000Z thumbnail image

Stay in the know with updates to Rucaparib and Nivolumab in Prostate or Endometrial Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Rucaparib and Nivolumab in Prostate or Endometrial Cancer Clinical Trial page.